Hypopituitarism after gamma knife radiosurgery for pituitary adenoma

References

• Jagannathan J, Yen CP, Pouratian N, Laws ER, Sheehan JP. Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the Gamma Knife. J Neuro-oncol 2009;92(3):345–356.
   PubMed Web of Science ®Google Scholar
• Laws ER, Sheehan JP, Sheehan JM, Jagnathan J, Jane JA, Jr., Oskouian R. Stereotactic radiosurgery for pituitary adenomas: a review of the literature. J Neuro-oncol 2004;69(1–3):257–272.
   PubMed Web of Science ®Google Scholar
• Leenstra JL, Tanaka S, Kline RW, Brown PD, Link MJ, Nippoldt TB, et al. Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas. Neurosurgery 2010;67(1):27–32.
   PubMed Web of Science ®Google Scholar
• Lee CC, Vance ML, Xu Z, Yen CP, Schlesinger D, Dodson B, et al. Stereotactic radiosurgery for acromegaly. J Clin Endocrinol Metab 2014;99(4):1273–1281.
   PubMed Web of Science ®Google Scholar
• Xu Z, Ellis S, Lee CC, Starke RM, Schlesinger D, Lee Vance M, et al. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study. Int J Radiat Oncol Biol Phys 2014;90(4):903–910.
   PubMed Web of Science ®Google Scholar
• Wilson PJ, De-Loyde KJ, Williams JR, Smee RI. Acromegaly: a single centre’s experience of stereotactic radiosurgery and radiotherapy for growth hormone secreting pituitary tumours with the linear accelerator. J Clin Neurosci 2013;20(11):1506–1513.
   PubMed Web of Science ®Google Scholar
• Gopalan R, Schlesinger D, Vance ML, Laws E, Sheehan J. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma. Neurosurgery 2011;69(2):284–293.
   PubMed Web of Science ®Google Scholar
• Iwai Y, Yamanaka K, Yoshioka K. Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery 2005;56(4):699–705.
   PubMed Web of Science ®Google Scholar
• Elson A, Bovi J, Kaur K, Maas D, Sinson G, Schultz C. Effect of treatment modality on the hypothalamic-pituitary function of patients treated with radiation therapy for pituitary adenomas: hypothalamic dose and endocrine outcomes. Front Oncol 2014;4:73.
   PubMedGoogle Scholar
• Fernandez A, Brada M, Zabuliene L, Karavitaki N, Wass JA. Radiation-induced hypopituitarism. Endocr Relat Cancer 2009;16(3):733–772.
   PubMed Web of Science ®Google Scholar
• Sicignano G, Losa M, del Vecchio A, Cattaneo GM, Picozzi P, Bolognesi A, et al. Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas. Radiother Oncol 2012;104(1):119–124.
   PubMed Web of Science ®Google Scholar
• Kong DS, Lee JI, Lim do H, Kim KW, Shin HJ, Nam DH, et al. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 2007;110(4):854–860.
   PubMed Web of Science ®Google Scholar
• Feigl GC, Pistracher K, Berghold A, Mokry M. Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus. J Neurosurg 2010 ;113 Suppl:153–159.
   Web of Science ®Google Scholar
• Agha A, Sherlock M, Brennan S, O’Connor SA, O’Sullivan E, Rogers B, et al. Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 2005;90(12):6355–6360.
   PubMed Web of Science ®Google Scholar
• Rieken S, Habermehl D, Welzel T, Mohr A, Lindel K, Debus J, et al. Long term toxicity and prognostic factors of radiation therapy for secreting and non-secreting pituitary adenomas. Radiation Oncol. 2013;8:18.
   PubMed Web of Science ®Google Scholar
• Pollock BE, Cochran J, Natt N, Brown PD, Erickson D, Link MJ, et al. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys 2008;70(5):1325–1329.
   PubMed Web of Science ®Google Scholar
• Darzy KH. Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Clin Pract Endocrinol Metab 2009;5(2):88–99.
   PubMedGoogle Scholar
• Sheehan JP, Niranjan A, Sheehan JM, Jane JA, Jr., Laws ER, Kondziolka D, et al. Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 2005;102(4):678–691.
   PubMed Web of Science ®Google Scholar
• Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, et al. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 2009;94(9):3400–3407.
   PubMed Web of Science ®Google Scholar
• Madaschi S, Fiorino C, Losa M, Lanzi R, Mazza E, Motta M, et al. Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors. Radiother Oncol 2011;99(1):23–28.
   PubMed Web of Science ®Google Scholar
• van den Bergh AC, van den Berg G, Schoorl MA, Sluiter WJ, van der Vliet AM, Hoving EW, et al. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys 2007;67(3):863–869.
   PubMed Web of Science ®Google Scholar
• Minniti G, Osti M, Jaffrain-Rea ML, Esposito V, Cantore G, Maurizi Enrici R. Long-term follow-up results of postoperative radiation therapy for Cushing’s disease. J Neuro-oncol 2007;84(1):79–84.
   PubMed Web of Science ®Google Scholar
• Kim W, Clelland C, Yang I, Pouratian N. Comprehensive review of stereotactic radiosurgery for medically and surgically refractory pituitary adenomas. Surg Neurol Int 2012;3(Suppl 2):S79–89.
   PubMedGoogle Scholar
• Merchant TE, Goloubeva O, Pritchard DL, Gaber MW, Xiong X, Danish RK, et al. Radiation dose-volume effects on growth hormone secretion. Int J Radiat Oncol Biol Phys 2002;52(5):1264–1270.
   PubMed Web of Science ®Google Scholar
• Torrens M, Chung C, Chung HT, Hanssens P, Jaffray D, Kemeny A, et al. Standardization of terminology in stereotactic radiosurgery: Report from the Standardization Committee of the International Leksell Gamma Knife Society: special topic Neurosurgery 2014; 121 Suppl:2–15.
   Google Scholar
• Kong DS, Lee JI, Lim DH, Kim KW, Shin HJ, Nam DH, et al. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 2007;110(4):854–860.
   PubMed Web of Science ®Google Scholar
• Park KJ, Kano H, Parry PV, Niranjan A, Flickinger JC, Lunsford LD, et al. Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas. Neurosurgery 2011;69(6):1188–1199.
   PubMed Web of Science ®Google Scholar
• Lee HM, Lee SH, Yang IH, Hwang IK, Hwang YC, Ahn KJ, et al. Acromegaly with Normal Insulin-Like Growth Factor-1 Levels and Congestive Heart Failure as the First Clinical Manifestation. Endocrinol Metab 2014 ;30(3): 395–401.
   Google Scholar
• Xu Z, Lee Vance M, Schlesinger D, Sheehan JP. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas. Neurosurgery 2013;72(4):630–637.
   Web of Science ®Google Scholar
• Chen Y, Li ZF, Zhang FX, Li JX, Cai L, Zhuge QC, et al. Gamma knife surgery for patients with volumetric classification of nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Eur J Endocrinol 2013;169(4):487–495.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Link MJ, Brown PD, Stafford SL, Young WF, Jr., Pollock BE. Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas. World Neurosurg 2010;74(1):147–152.
   PubMed Web of Science ®Google Scholar
• Ronchi CL, Attanasio R, Verrua E, Cozzi R, Ferrante E, Loli P, et al. Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study. Clin Endocrinol 2009;71(6):846–852.
   PubMed Web of Science ®Google Scholar
• Hoybye C, Grenback E, Rahn T, Degerblad M, Thoren M, Hulting AL. Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 2001;49(2): 284–291.
   PubMed Web of Science ®Google Scholar